Clinical Trial Update: A Pilot Study to Assess microRNA Biomarkers in Early and Later Stage Multiple Sclerosis

View source ↗

Summary

This update reports the results of a pilot study evaluating microRNA biomarkers in early and later stages of multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clinically Isolated Syndrome
• Multiple Sclerosis
• Progressive Multiple Sclerosis

Snippet

Sponsor: John F. Foley, MD | Conditions: Multiple Sclerosis, Secondary Progressive Multiple Sclerosis | Status: COMPLETED